Frits Van Rhee - JoVE Visualize

Showing results (181-190 of 233) with videos related to

Pageof 24

Sort By:

Blood|May 27, 2006

The molecular classification of multiple myelomaFenghuang Zhan, Yongsheng Huang, Simona Colla, et al.

Blood|April 23, 2013

Risk factors for MDS and acute leukemia following total therapy 2 and 3 for multiple myelomaSaad Z Usmani, Jeffrey Sawyer, Adam Rosenthal, et al.

Theranostics|August 2, 2019

Lack of Spleen Signal on Diffusion Weighted MRI is associated with High Tumor Burden and Poor Prognosis in Multiple Myeloma: A Link to Extramedullary Hematopoiesis?Leo Rasche, Manoj Kumar, Grant Gershner, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 14, 2007

Magnetic resonance imaging in multiple myeloma: diagnostic and clinical implicationsRonald Walker, Bart Barlogie, Jeffrey Haessler, et al.

British Journal of Haematology|June 27, 2007

Incorporating bortezomib into upfront treatment for multiple myeloma: early results of total therapy 3Bart Barlogie, Elias Anaissie, Frits van Rhee, et al.

Blood Cancer Journal|November 6, 2024

Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stagesYan Cheng, Fumou Sun, Daisy V Alapat, et al.

The Journal of Clinical Investigation|July 26, 2022

CST6 suppresses osteolytic bone disease in multiple myeloma by blocking osteoclast differentiationDongzheng Gai, Jin-Ran Chen, James P Stewart, et al.

Blood Cancer Journal|June 20, 2020

Genomic analysis of primary plasma cell leukemia reveals complex structural alterations and high-risk mutational patternsCarolina Schinke, Eileen M Boyle, Cody Ashby, et al.

Current Research in Translational Medicine|April 24, 2021

PHF19 inhibition as a therapeutic target in multiple myelomaCarolina D Schinke, Jordan T Bird, Pingping Qu, et al.

Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 22, 2014

Ex vivo-expanded natural killer cells demonstrate robust proliferation in vivo in high-risk relapsed multiple myeloma patientsSusann Szmania, Natalia Lapteva, Tarun Garg, et al.

Pageof 24

Showing results (181-190 of 233) with videos related to

Sort By:

Pageof 24

Blood|May 27, 2006

The molecular classification of multiple myelomaFenghuang Zhan, Yongsheng Huang, Simona Colla, et al.

Blood|April 23, 2013

Risk factors for MDS and acute leukemia following total therapy 2 and 3 for multiple myelomaSaad Z Usmani, Jeffrey Sawyer, Adam Rosenthal, et al.

Theranostics|August 2, 2019

Lack of Spleen Signal on Diffusion Weighted MRI is associated with High Tumor Burden and Poor Prognosis in Multiple Myeloma: A Link to Extramedullary Hematopoiesis?Leo Rasche, Manoj Kumar, Grant Gershner, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 14, 2007

Magnetic resonance imaging in multiple myeloma: diagnostic and clinical implicationsRonald Walker, Bart Barlogie, Jeffrey Haessler, et al.

British Journal of Haematology|June 27, 2007

Incorporating bortezomib into upfront treatment for multiple myeloma: early results of total therapy 3Bart Barlogie, Elias Anaissie, Frits van Rhee, et al.

Blood Cancer Journal|November 6, 2024

Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stagesYan Cheng, Fumou Sun, Daisy V Alapat, et al.

The Journal of Clinical Investigation|July 26, 2022

CST6 suppresses osteolytic bone disease in multiple myeloma by blocking osteoclast differentiationDongzheng Gai, Jin-Ran Chen, James P Stewart, et al.

Blood Cancer Journal|June 20, 2020

Genomic analysis of primary plasma cell leukemia reveals complex structural alterations and high-risk mutational patternsCarolina Schinke, Eileen M Boyle, Cody Ashby, et al.

Current Research in Translational Medicine|April 24, 2021

PHF19 inhibition as a therapeutic target in multiple myelomaCarolina D Schinke, Jordan T Bird, Pingping Qu, et al.

Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 22, 2014

Ex vivo-expanded natural killer cells demonstrate robust proliferation in vivo in high-risk relapsed multiple myeloma patientsSusann Szmania, Natalia Lapteva, Tarun Garg, et al.

Pageof 24